advertisement
Ropo A 1
Showing records 1 to 1 | Display all abstracts from Ropo A57052 Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients
Holló G; Hommer A; Antón López A; Ropo A
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 468-475
